Hemato is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2020. The journal covers Medicine.
Authors are required to pay an article processing charge to publish in Hemato; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
lymphoid leukemias, immunogenetics, non neoplastic blood disorders, transplantation, target therapy, immunobiology
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2020
ISSN
- electronic
- 2673-6357
Frequently asked questions
Is Hemato peer-reviewed?
Yes — Hemato operates a Anonymous peer review review process.
Does Hemato charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Hemato publish?
Hemato publishes research in Medicine.
What languages does Hemato accept?
Hemato accepts manuscripts in English.
What is the ISSN of Hemato?
ISSN:
2673-6357 (electronic).How do I submit a manuscript to Hemato?
Submit through the journal's official portal: visit submission page →